MAB'Solut Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
MAB'Solut General Information
Description
Developer of monoclonal antibodies. The company is engaged in the research and development of immune antibodies for the treatment of ophthalmic diseases, cancers, autoimmune and inflammatory diseases.
Contact Information
Website
www.mabsolut.comCorporate Office
- Génopole Campus 1
- 5 rue Henri Desbruères
- 91030 Evry Cedex
- France
Corporate Office
- Génopole Campus 1
- 5 rue Henri Desbruères
- 91030 Evry Cedex
- France
MAB'Solut Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MAB'Solut Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MAB'Solut FAQs
-
Where is MAB'Solut headquartered?
MAB'Solut is headquartered in Evry Cedex, France.
-
What industry is MAB'Solut in?
MAB'Solut’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is MAB'Solut a private or public company?
MAB'Solut is a Private company.
-
What is MAB'Solut’s current revenue?
The current revenue for MAB'Solut is 00000.
-
Who are MAB'Solut’s investors?
MABLife has invested in MAB'Solut.
-
When was MAB'Solut acquired?
MAB'Solut was acquired on 22-Apr-2015.
-
Who acquired MAB'Solut?
MAB'Solut was acquired by MABSolys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
